Literature DB >> 15587763

What's wrong with prescribing hypnotics?

.   

Abstract

Expert bodies have long advised that use of hypnotic drugs should be limited to short courses for acutely distressed patients and should generally be avoided in elderly people. Despite this, more than 10 million prescriptions for hypnotics continue to be dispensed each year in England alone, mostly for benzodiazepines and drugs with similar actions such as zaleplon, zolpidem and zopiclone (so called 'Z-drugs'). Around 80% of all such prescriptions are for people aged 65 years or over, and many patients remain on the drugs for months or years. Such prescribing carries many potential hazards for patients, including risk of dependence, accidents and other adverse effects on health. Here we review how the risks from hypnotic drugs can be minimised.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15587763     DOI: 10.1136/dtb.2004.421289

Source DB:  PubMed          Journal:  Drug Ther Bull        ISSN: 0012-6543


  6 in total

1.  Psychotropic drug use among older people in general practice: discrepancies between opinion and practice.

Authors:  Andrea Lasserre; Nadia Younès; Thierry Blanchon; Inge Cantegreil-Kallen; Christine Passerieux; Guy Thomas; Christine Chan-Chee; Thomas Hanslik
Journal:  Br J Gen Pract       Date:  2010-04       Impact factor: 5.386

Review 2.  Clinical diagnosis and misdiagnosis of sleep disorders.

Authors:  G Stores
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-12       Impact factor: 10.154

3.  Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care.

Authors:  A Niroshan Siriwardena; M Zubair Qureshi; Jane V Dyas; Hugh Middleton; Roderick Orner
Journal:  Br J Gen Pract       Date:  2008-06       Impact factor: 5.386

4.  Antidepressants for the treatment of insomnia : a suitable approach?

Authors:  Michael H Wiegand
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 5.  Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.

Authors:  André S Pollmann; Andrea L Murphy; Joel C Bergman; David M Gardner
Journal:  BMC Pharmacol Toxicol       Date:  2015-07-04       Impact factor: 2.483

6.  Evaluation of effectiveness and safety of a herbal compound in primary insomnia symptoms and sleep disturbances not related to medical or psychiatric causes.

Authors:  Giancarlo Palmieri; Paola Contaldi; Giuseppe Fogliame
Journal:  Nat Sci Sleep       Date:  2017-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.